Literature DB >> 22160184

New similarity search based glioma grading.

Katrin Haegler1, Martin Wiesmann, Christian Böhm, Jessica Freiherr, Oliver Schnell, Hartmut Brückmann, Jörg-Christian Tonn, Jennifer Linn.   

Abstract

INTRODUCTION: MR-based differentiation between low- and high-grade gliomas is predominately based on contrast-enhanced T1-weighted images (CE-T1w). However, functional MR sequences as perfusion- and diffusion-weighted sequences can provide additional information on tumor grade. Here, we tested the potential of a recently developed similarity search based method that integrates information of CE-T1w and perfusion maps for non-invasive MR-based glioma grading.
METHODS: We prospectively included 37 untreated glioma patients (23 grade I/II, 14 grade III gliomas), in whom 3T MRI with FLAIR, pre- and post-contrast T1-weighted, and perfusion sequences was performed. Cerebral blood volume, cerebral blood flow, and mean transit time maps as well as CE-T1w images were used as input for the similarity search. Data sets were preprocessed and converted to four-dimensional Gaussian Mixture Models that considered correlations between the different MR sequences. For each patient, a so-called tumor feature vector (= probability-based classifier) was defined and used for grading. Biopsy was used as gold standard, and similarity based grading was compared to grading solely based on CE-T1w.
RESULTS: Accuracy, sensitivity, and specificity of pure CE-T1w based glioma grading were 64.9%, 78.6%, and 56.5%, respectively. Similarity search based tumor grading allowed differentiation between low-grade (I or II) and high-grade (III) gliomas with an accuracy, sensitivity, and specificity of 83.8%, 78.6%, and 87.0%.
CONCLUSION: Our findings indicate that integration of perfusion parameters and CE-T1w information in a semi-automatic similarity search based analysis improves the potential of MR-based glioma grading compared to CE-T1w data alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160184     DOI: 10.1007/s00234-011-0988-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  27 in total

1.  Improving lesion-symptom mapping.

Authors:  Chris Rorden; Hans-Otto Karnath; Leonardo Bonilha
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

2.  Applying spatial distribution analysis techniques to classification of 3D medical images.

Authors:  Dragoljub Pokrajac; Vasileios Megalooikonomou; Aleksandar Lazarevic; Despina Kontos; Zoran Obradovic
Journal:  Artif Intell Med       Date:  2005-03       Impact factor: 5.326

3.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

4.  Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE.

Authors:  Carles Majós; Margarida Julià-Sapé; Juli Alonso; Marta Serrallonga; Carles Aguilera; Juan J Acebes; Carles Arús; Jaume Gili
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

5.  Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.

Authors:  Rishi Awasthi; Ram K S Rathore; Priyanka Soni; Prativa Sahoo; Ashish Awasthi; Nuzhat Husain; Sanjay Behari; Rohit K Singh; Chandra M Pandey; Rakesh K Gupta
Journal:  Neuroradiology       Date:  2011-05-04       Impact factor: 2.804

6.  Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons.

Authors:  Devyani Bedekar; Todd Jensen; Kathleen M Schmainda
Journal:  Magn Reson Med       Date:  2010-09       Impact factor: 4.668

7.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

8.  Perfusion MR imaging in gliomas: comparison with histologic tumor grade.

Authors:  S J Lee; J H Kim; Y M Kim; G K Lee; E J Lee; I S Park; J M Jung; K H Kang; T Shin
Journal:  Korean J Radiol       Date:  2001 Jan-Mar       Impact factor: 3.500

9.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

10.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.

Authors:  Ji Hoon Shin; Ho Kyu Lee; Byung Duk Kwun; Jin-Suh Kim; Weechang Kang; Choong Gon Choi; Dae Chul Suh
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more
  5 in total

1.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

2.  Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.

Authors:  Cornelia Brendle; Johann-Martin Hempel; Jens Schittenhelm; Marco Skardelly; Ghazaleh Tabatabai; Benjamin Bender; Ulrike Ernemann; Uwe Klose
Journal:  Clin Neuroradiol       Date:  2017-05-09       Impact factor: 3.649

3.  Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Authors:  Egesta Lopci; Marco Riva; Laura Olivari; Fabio Raneri; Riccardo Soffietti; Arnoldo Piccardo; Alberto Bizzi; Pierina Navarria; Anna Maria Ascolese; Roberta Rudà; Bethania Fernandes; Federico Pessina; Marco Grimaldi; Matteo Simonelli; Marco Rossi; Tommaso Alfieri; Paolo Andrea Zucali; Marta Scorsetti; Lorenzo Bello; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-21       Impact factor: 9.236

4.  Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensities.

Authors:  Max-Ludwig Schäfer; Martin H Maurer; Michael Synowitz; Joost Wüstefeld; Tim Marnitz; Florian Streitparth; Edzard Wiener
Journal:  Eur Radiol       Date:  2013-05-19       Impact factor: 5.315

Review 5.  Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.

Authors:  Fred H Hochberg; Nadia A Atai; David Gonda; Michael S Hughes; Brolin Mawejje; Leonora Balaj; Robert S Carter
Journal:  Expert Rev Mol Diagn       Date:  2014-05       Impact factor: 5.225

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.